about
Immunology of hematopoietic stem cell transplant.Clinical Role of Human Leukocyte Antigen in Health and Disease.Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer.HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.Serum interleukin-17 in Egyptian children with systemic lupus erythematosus: is it related to pulmonary affection?Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis.TIM-1 rs41297579 G>A (-1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity.Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis.Tumor necrosis factor-α -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus.CAG repeat length in androgen receptor gene and male infertility in Egyptian patients.Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis.Interferon-gamma +874 T/A and interleukin-10 -1082 A/G single nucleotide polymorphism in Egyptian children with tuberculosis.Association of human leucocyte antigen Class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in Egyptian patients.GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact.IRF5, PTPN22, CD28, IL2RA, KIF5A, BLK and TNFAIP3 genes polymorphisms and lupus susceptibility in a cohort from the Egypt Delta; relation to other ethnic groups.Association between Human Leukocyte Antigens (HLA-A, -B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation.Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients.Association between CD266 polymorphism and soluble levels in rheumatoid arthritis: Relationship with clinical activity.GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosusAssociation between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCVComparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patientsEndothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among EgyptiansARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome
P50
Q38258161-8AD16F53-645D-4064-898A-55FE56B97548Q38534421-035F8F46-DDD9-4B9B-995A-A4F02E669CA6Q38883781-58EB7CEA-105A-4622-9E95-4EF730ADB5F9Q38986624-F45FCE33-5F30-4A0B-88AD-4A9321BAF355Q38989961-35872A59-BE22-4962-8C63-BD0D1D9A2E2FQ39043261-E0533CEC-2FA4-4945-8917-90BC2280DB4DQ39043265-882CB86C-685E-43A0-AE98-9F10F62F2C4CQ39272808-F13BBB47-40AF-43DB-9645-435B51883BE8Q39272815-13E38BA9-61E0-4CCF-BF08-B0CF6ABB1A7EQ39272819-DAED50C9-B33A-4781-9CBD-3FE8E1EE42E3Q39272828-5614B85F-CF79-4B13-BC8F-756B33FC4FD1Q39272836-E43B8C95-3704-4DA0-91C6-36CC1E36F554Q39272843-4B940626-59E5-47D7-80D0-A3BB8EA3BFC8Q39272864-1C58E747-B8F8-4187-AFDB-B81EBAD0A27EQ39272880-2B366BA1-51E7-4B3F-A510-EE8430F7AA97Q39272896-65DCD9AB-74FD-4156-91E9-1675D8749A13Q40086982-19B76AE7-6557-4F27-8D9E-C3F78391954FQ41656213-FE600FA5-A9D0-48AF-A671-7E28B4E8086AQ46224874-153AABF0-E435-4883-AA4D-0CD6D314B2EAQ46251444-285F335E-4CB3-4CBE-A077-FCEA91DB029BQ46489677-7D374B97-7A3D-4D61-B123-49E0AA63BB79Q46753736-64CF62FA-77F4-4A41-8AE2-296443DABD4BQ48271582-8350977B-A326-4576-905B-0ADDBDA13FEBQ57291043-8B8A48F2-81D2-4CCF-8F43-193AD6483BA4Q57462958-016EEAEF-4994-44BD-8B2B-5F1340A116DDQ64387269-B66BE448-0ED2-49C9-8CA1-17430C425682Q90785922-985795A3-ED83-46DA-8E54-0A1C6C3D19A5Q92691262-CFEB5430-EB87-4C2F-A3DE-9928597D35DF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Youssef M Mosaad
@en
Youssef M Mosaad
@nl
type
label
Youssef M Mosaad
@en
Youssef M Mosaad
@nl
prefLabel
Youssef M Mosaad
@en
Youssef M Mosaad
@nl
P31
P496
0000-0002-7148-0983